August 18, 2023
US, Japan and South Korea condemn ‘dangerous and aggressive actions’ by China
CAMP DAVID, Maryland (Reuters) – The United States prevailed on Japan and South Korea on Friday to use their strongest…
Major takeaways from US, Japan, South Korea summit
By Trevor Hunnicutt and Hyonhee Shin CAMP DAVID, Maryland (Reuters) -U.S. President Joe Biden, Japanese Prime Minister Fumio Kishida and…
At Camp David, US, South Korea and Japan condemn China, agree to deepen military ties
By Trevor Hunnicutt, David Brunnstrom and Hyonhee Shin CAMP DAVID, Maryland (Reuters) -U.S. President Joe Biden and the leaders of…
Latest North Korean missile sparks debate over possible Russian links
By Josh Smith, Trevor Hunnicutt and David Brunnstrom SEOUL/WASHINGTON (Reuters) -North Korea’s latest Hwasong-18 intercontinental ballistic missile – its first…
Norway fund wants more women on boards, concerned about excessive CEO pay
By Gwladys Fouche ARENDAL, Norway (Reuters) – Norway’s $1.4 trillion wealth fund, the world’s single largest stock market investor, is…
Evergrande seeks US court nod for $32 billion debt overhaul as China economic fears mount
By Clare Jim, Jonathan Stempel and Dietrich Knauth HONG KONG/NEW YORK (Reuters) – Embattled developer China Evergrande Group has filed…
West African bloc says ‘D-Day’ set for possible Niger intervention
By Maxwell Akalaare Adombila ACCRA (Reuters) – West Africa’s main regional bloc on Friday said it had agreed an undisclosed…
Trump to skip Republican debate, interview with ex-Fox host Carlson -NYT
WASHINGTON (Reuters) -Former U.S. President Donald Trump plans to skip the first Republican primary debate next week and instead sit…
S&P 500 ends near flat as energy, defensive sectors counter megacap declines
By Saeed Azhar and Amruta Khandekar NEW YORK (Reuters) – The S&P 500 ended nearly flat on Friday as gains…
US FDA approves Regeneron’s ultra-rare blood disease drug
By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its drug to treat a rare…
